Harmeet Bhullar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Harmeet Bhullar has a total of 30 co-authors. Here are the top co-authors by number of shared publications:
- David James Hunter-Smith
Department of Plastic, Reconstructive and Hand Surgery, Peninsula Health, Frankston, Victoria, Australia
2 shared publications - Warren Matthew Rozen
Peninsula Health
2 shared publications A. Saracino
Royal Melbourne Hospital, Melbourne, Victoria, Australia
1 shared publicationAmanda M Saracino
Department of Dermatology, St Vincent’s Hospital, Melbourne, Melbourne, VIC, Australia
1 shared publication- Ar Kar Aung
Department of General Medicine Alfred Health Melbourne Victoria Australia
1 shared publication - Bing Mei Teh
Ear, Nose and Throat Department, Alfred Health, 55 Commercial Road, Melbourne, 3004, Victoria, Australia; Department of Surgery, Monash University, Victoria, Australia
1 shared publication
Latest Publications
- Open Access
- 14 April 2026
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (4)
Complete Skin Remission of Lichen Planus With Tirzepatide
- 14 April 2026
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 67 (4)
Open AccessComplete Skin Remission of Lichen Planus With Tirzepatide
- 21 November 2024
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (1) , 32-35
Complete skin remission of Sneddon‐Wilkinson disease with acalabrutinib
Sneddon‐Wilkinson (SW) disease is rare condition which typically occurs in the context of a monoclonal immunoglobulin and treatment options have not been well studied. Here we present a case of a 65‐year‐old female with SW with underlying, otherwise indolent, lymphoplasmacytic lymphoma (LPL) with an IgA paraprotein, who achieved a complete skin remission with the administration of the Bruton Tyrosine Kinase inhibitor (BTKi), acalabrutinib.
- 21 November 2024
- Published by Wiley in Australasian Journal of Dermatology
- Vol. 66 (1) , 32-35
Complete skin remission of Sneddon‐Wilkinson disease with acalabrutinib
Sneddon‐Wilkinson (SW) disease is rare condition which typically occurs in the context of a monoclonal immunoglobulin and treatment options have not been well studied. Here we present a case of a 65‐year‐old female with SW with underlying, otherwise indolent, lymphoplasmacytic lymphoma (LPL) with an IgA paraprotein, who achieved a complete skin remission with the administration of the Bruton Tyrosine Kinase inhibitor (BTKi), acalabrutinib.
- 28 May 2024
- Published by BMJ in Journal of Scleroderma and Related Disorders
- Vol. 9 (3) , NP1-NP4
Atypical morphoea, a herald of two malignancies: Lung adenocarcinoma and a neuroendocrine tumour
Introduction: Morphoea is a disorder characterised by fibrosis and inflammation of the skin and on rare occasions can be precipitated by malignancy. Here, we describe a case of morphoea unmasking two malignancies. Case description: A 73-year-old woman presented with circumferential lower limb skin thickening, associated with violaceous, doughy oedema and significantly impaired mobility. Histology confirmed dermal sclerosis with no increased mucin and broader investigations excluded systemic sclerosis, scleromyxoedema and scleroedema. An atypical morphoea was diagnosed. In the context of atypical and subsequently treatment-resistant disease, further imaging uncovered a lung adenocarcinoma which was promptly treated. Despite this, the patient’s atypical oedematous skin sclerosis continued to progress proximally, and she developed flatulence, bloating and atypical flushing. This prompted further investigation, which revealed a metastatic neuroendocrine tumour. The patient was commenced on octreotide, with rapid improvement in all her cutaneous and systemic symptoms. Conclusion: Atypical morphoea can be a herald for an underlying malignancy, representing a paraneoplastic presentation. Progressive treatment-resistant morphoea may be an indicator of metastatic disease, or in our case a second malignancy.
- 28 May 2024
- Published by BMJ in Journal of Scleroderma and Related Disorders
- Vol. 9 (3) , NP1-NP4
Atypical morphoea, a herald of two malignancies: Lung adenocarcinoma and a neuroendocrine tumour
Introduction: Morphoea is a disorder characterised by fibrosis and inflammation of the skin and on rare occasions can be precipitated by malignancy. Here, we describe a case of morphoea unmasking two malignancies. Case description: A 73-year-old woman presented with circumferential lower limb skin thickening, associated with violaceous, doughy oedema and significantly impaired mobility. Histology confirmed dermal sclerosis with no increased mucin and broader investigations excluded systemic sclerosis, scleromyxoedema and scleroedema. An atypical morphoea was diagnosed. In the context of atypical and subsequently treatment-resistant disease, further imaging uncovered a lung adenocarcinoma which was promptly treated. Despite this, the patient’s atypical oedematous skin sclerosis continued to progress proximally, and she developed flatulence, bloating and atypical flushing. This prompted further investigation, which revealed a metastatic neuroendocrine tumour. The patient was commenced on octreotide, with rapid improvement in all her cutaneous and systemic symptoms. Conclusion: Atypical morphoea can be a herald for an underlying malignancy, representing a paraneoplastic presentation. Progressive treatment-resistant morphoea may be an indicator of metastatic disease, or in our case a second malignancy.
- Open Access
- 31 March 2022
- Published by Australian Society of Plastic Surgeons in Australasian Journal of Plastic Surgery
- Vol. 5 (1) , 80-87
Enhanced risk of multiple sentinel lymph node basins in truncal and head and neck melanoma
# IntroductionTruncal and head and neck head and neck melanomas have a greater propensity to drain to multiple lymph node basins (MLNB) compared to extremity melanomas, which drain predominantly to a single lymph node basin (SLNB). The objective of this study was to compare the lymphatic drainage patterns and characteristics of truncal and head and neck melanoma, to assess their clinical usefulness in areas of unpredictable drainage. # MethodsA retrospective review of 143 patients with head and neck or truncal melanoma from 2014–2018 treated at the Victorian Melanoma Service, Alfred Hospital, Melbourne, Australia. Patients scheduled for a wide local excision (WLE) and SeNBx, and those whose initial biopsy results stated melanoma type, cell type and BT, were included. Patients were excluded if they underwent nodal biopsy alone.# ResultsWe identified 95 patients with truncal and 48 with head and neck melanoma. Drainage to MLNB was significantly higher in the truncal melanoma group (36.8%) compared to the head and neck group (10.4%) (_p_ = 0.001). Patients with drainage to MLNB had a higher positive sentinel node biopsy (SeNBx) rate compared to those with SLNB (40.0% verus. 12.6%, _p_ <0.0001). Truncal melanomas that drained to MLNB were associated with a significantly higher Breslow thickness (2.1 versus. 1.5, _p_ = 0.02), ulceration (40.6% vs. 20.7%, _p_ = 0.043) and mitotic rate (3.0 versus. 2.0, _p_ = 0.045) compared to equivalent melanomas that drained to SLNB. # ConclusionPatients with melanomas occurring in the trunk exhibit higher rates of drainage to MLNB compared to melanomas arising in the head and neckhead and neck. Patients with drainage to MLNB also demonstrate a higher rate of positive SeNBx than those with SLNB drainage. This may represent more aggressive disease pathology or later diagnosis of lesions within these locations, or a lymphatic system that is more facilitatory of spread.
- 31 March 2022
- Published by Australian Society of Plastic Surgeons in Australasian Journal of Plastic Surgery
- Vol. 5 (1) , 80-87
Open AccessEnhanced risk of multiple sentinel lymph node basins in truncal and head and neck melanoma
# IntroductionTruncal and head and neck head and neck melanomas have a greater propensity to drain to multiple lymph node basins (MLNB) compared to extremity melanomas, which drain predominantly to a single lymph node basin (SLNB). The objective of this study was to compare the lymphatic drainage patterns and characteristics of truncal and head and neck melanoma, to assess their clinical usefulness in areas of unpredictable drainage. # MethodsA retrospective review of 143 patients with head and neck or truncal melanoma from 2014–2018 treated at the Victorian Melanoma Service, Alfred Hospital, Melbourne, Australia. Patients scheduled for a wide local excision (WLE) and SeNBx, and those whose initial biopsy results stated melanoma type, cell type and BT, were included. Patients were excluded if they underwent nodal biopsy alone.# ResultsWe identified 95 patients with truncal and 48 with head and neck melanoma. Drainage to MLNB was significantly higher in the truncal melanoma group (36.8%) compared to the head and neck group (10.4%) (_p_ = 0.001). Patients with drainage to MLNB had a higher positive sentinel node biopsy (SeNBx) rate compared to those with SLNB (40.0% verus. 12.6%, _p_ <0.0001). Truncal melanomas that drained to MLNB were associated with a significantly higher Breslow thickness (2.1 versus. 1.5, _p_ = 0.02), ulceration (40.6% vs. 20.7%, _p_ = 0.043) and mitotic rate (3.0 versus. 2.0, _p_ = 0.045) compared to equivalent melanomas that drained to SLNB. # ConclusionPatients with melanomas occurring in the trunk exhibit higher rates of drainage to MLNB compared to melanomas arising in the head and neckhead and neck. Patients with drainage to MLNB also demonstrate a higher rate of positive SeNBx than those with SLNB drainage. This may represent more aggressive disease pathology or later diagnosis of lesions within these locations, or a lymphatic system that is more facilitatory of spread.
- 22 May 2020
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 44 (5) , 1454-1461
Fat Necrosis After DIEP Flap Breast Reconstruction: A Review of Perfusion-Related Causes
Introduction Fat necrosis is a common complication for the deep inferior epigastric perforator (DIEP) flap. A thorough understanding of the factors associated with fat necrosis will aid operative planning for reconstructive surgeons. Methods A systematic review of the literature was performed between January 1989 and April 2019. Studies were included if they reported on fat necrosis in DIEP flap or evaluated the perfusion of the DIEP flap. Twenty-eight out of 312 studies met the inclusion and exclusion criteria. Results Fat necrosis rates ranged from 12.0 to 45.0% on clinical examination within the literature. The four main perforator-specific factors identified included perforator perfusion zones, perforator location, perforator number and venous congestion. Medial row perforators have a wider perfusion zone, while lateral row perforators have a narrow perfusion zone. Holm zone III has a higher rate of fat necrosis compared to Holm zone II. One to two perforators and more than five perforators and a Type III atypical connection between the superficial and deep venous system had a higher rate of fat necrosis. Conclusion The DIEP flap should incorporate between two and three perforators of a substantial calibre; Holm zone III should be excluded if able and careful review of the pre-operative imaging should be performed to analyse the connections between the deep and superficial venous system. There are multiple perfusion-related factors to consider when planning the DIEP flap and ultimately a patient-specific approach to the vascular anatomy is essential. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 22 May 2020
- Published by Springer Nature in Aesthetic Plastic Surgery
- Vol. 44 (5) , 1454-1461
Fat Necrosis After DIEP Flap Breast Reconstruction: A Review of Perfusion-Related Causes
Introduction Fat necrosis is a common complication for the deep inferior epigastric perforator (DIEP) flap. A thorough understanding of the factors associated with fat necrosis will aid operative planning for reconstructive surgeons. Methods A systematic review of the literature was performed between January 1989 and April 2019. Studies were included if they reported on fat necrosis in DIEP flap or evaluated the perfusion of the DIEP flap. Twenty-eight out of 312 studies met the inclusion and exclusion criteria. Results Fat necrosis rates ranged from 12.0 to 45.0% on clinical examination within the literature. The four main perforator-specific factors identified included perforator perfusion zones, perforator location, perforator number and venous congestion. Medial row perforators have a wider perfusion zone, while lateral row perforators have a narrow perfusion zone. Holm zone III has a higher rate of fat necrosis compared to Holm zone II. One to two perforators and more than five perforators and a Type III atypical connection between the superficial and deep venous system had a higher rate of fat necrosis. Conclusion The DIEP flap should incorporate between two and three perforators of a substantial calibre; Holm zone III should be excluded if able and careful review of the pre-operative imaging should be performed to analyse the connections between the deep and superficial venous system. There are multiple perfusion-related factors to consider when planning the DIEP flap and ultimately a patient-specific approach to the vascular anatomy is essential. Level of Evidence III This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266.
- 3 September 2019
- Published by Wiley in Anz Journal of Surgery
- Vol. 90 (5) , 907-908
Demonstration of superficial venous dominance in the deep inferior epigastric perforator flap
- 3 September 2019
- Published by Wiley in Anz Journal of Surgery
- Vol. 90 (5) , 907-908
Demonstration of superficial venous dominance in the deep inferior epigastric perforator flap
- 6 December 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 178 (1) , E28-E29
Mastocytosis: a case series of 107 consecutive patients
- 6 December 2017
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 178 (1) , E28-E29
Mastocytosis: a case series of 107 consecutive patients